The presentation describes the expansion for routine immunization from district level to community level in Africa. Reaching remote communities is important to bring immunization to all children.
Transitioning from reaching every district to reaching every communityJSI
This presentation focuses on learning acquired from the last 2-3 year effort in 8 districts across both Uganda and Ethiopia and REC-QI potential to add to the arsenal of RI strengthening tools. REC is now the number one approach to reaching hard-to-reach health facilities. Adding Quality improvement to RED/REC will combine the “what” (RED/REC) and “how” (QI) factors to strengthening for sustainable improvement in coverage and brings together all EPI stakeholders. In addition, by working at both national and lower level, REC-QI encourages peer learning and incorporation of innovations into national policies, guidelines, and protocols.
RMNCH + A MCH Program Dr Girish .B Associate Professor, CIMS, ChamarajanagarDr Girish B
RMNCH + A MCH Program Dr Girish .B Associate Professor, Department of Community Medicine, Chamarajanagar Institute of Medical Sciences (CIMS), Chamarajanagar
Transitioning from reaching every district to reaching every communityJSI
This presentation focuses on learning acquired from the last 2-3 year effort in 8 districts across both Uganda and Ethiopia and REC-QI potential to add to the arsenal of RI strengthening tools. REC is now the number one approach to reaching hard-to-reach health facilities. Adding Quality improvement to RED/REC will combine the “what” (RED/REC) and “how” (QI) factors to strengthening for sustainable improvement in coverage and brings together all EPI stakeholders. In addition, by working at both national and lower level, REC-QI encourages peer learning and incorporation of innovations into national policies, guidelines, and protocols.
RMNCH + A MCH Program Dr Girish .B Associate Professor, CIMS, ChamarajanagarDr Girish B
RMNCH + A MCH Program Dr Girish .B Associate Professor, Department of Community Medicine, Chamarajanagar Institute of Medical Sciences (CIMS), Chamarajanagar
National kala azar elimination programme pptanjalatchi
Kala-azar is a slow progressing indigenous disease caused by a protozoan parasite of genus Leishmania
In India Leishmania donovani is the only parasite causing this disease
The parasite primarily infects reticuloendothelial system and may be found in abundance in bone marrow, spleen and liver.
Post Kala-azar Dermal Leishmaniasis (PKDL) is a condition when Leishmania donovani invades skin cells, resides and develops there and manifests as dermal leisions. Some of the kala-azar cases manifests PKDL after a few years of treatment. Recently it is believed that PKDL may appear without passing through visceral stage. However, adequate data is yet to be generated on course of PKDL manifestation
National framework for malaria elimination in indiaAparna Chaudhary
outlines India’s strategy for elimination of the disease by 2030. The framework has been developed with a vision to eliminate malaria from the country and contribute to improved health and quality of life and alleviation of poverty.
JSI Presentation; By Lora Shimp; April 2015. This presentation illustrates the Newborn Tracking and Monitoring of Infant Vaccination Status using My Village My Home (MVMH: Malawi). MVMH is a community based new born tracking tool to identify and track all infants in a community recording infant vaccination dates. MVMH is linked with the REC approach (4th and 5th elements) empowering community leaders and volunteers to engage with caretakers on health promotion specific to vaccinating their children, as well as, taking ownership in the success of the immunization progress.
Data quality and use (immunization and ict context) (4)JSI
This presentation outlines JSI's Experience in over 30 countries for over 35 years – technical support in immunization, RMNCH, logistics, technology and software development, M&E. By Lora Shimp, Senior Immunization Technical Officer
National kala azar elimination programme pptanjalatchi
Kala-azar is a slow progressing indigenous disease caused by a protozoan parasite of genus Leishmania
In India Leishmania donovani is the only parasite causing this disease
The parasite primarily infects reticuloendothelial system and may be found in abundance in bone marrow, spleen and liver.
Post Kala-azar Dermal Leishmaniasis (PKDL) is a condition when Leishmania donovani invades skin cells, resides and develops there and manifests as dermal leisions. Some of the kala-azar cases manifests PKDL after a few years of treatment. Recently it is believed that PKDL may appear without passing through visceral stage. However, adequate data is yet to be generated on course of PKDL manifestation
National framework for malaria elimination in indiaAparna Chaudhary
outlines India’s strategy for elimination of the disease by 2030. The framework has been developed with a vision to eliminate malaria from the country and contribute to improved health and quality of life and alleviation of poverty.
JSI Presentation; By Lora Shimp; April 2015. This presentation illustrates the Newborn Tracking and Monitoring of Infant Vaccination Status using My Village My Home (MVMH: Malawi). MVMH is a community based new born tracking tool to identify and track all infants in a community recording infant vaccination dates. MVMH is linked with the REC approach (4th and 5th elements) empowering community leaders and volunteers to engage with caretakers on health promotion specific to vaccinating their children, as well as, taking ownership in the success of the immunization progress.
Data quality and use (immunization and ict context) (4)JSI
This presentation outlines JSI's Experience in over 30 countries for over 35 years – technical support in immunization, RMNCH, logistics, technology and software development, M&E. By Lora Shimp, Senior Immunization Technical Officer
In Nigeria, the USAID-funded Targeted States High Impact Project (TSHIP)'s chlorhexidine and misoprostol program is saving the lives of mothers and newborns, strengthening local health systems, and boosting local economy.
TSHIP Chief of Party Nosa Orobaton presented a slideshow depicting beneficiaries of TSHIP's groundbreaking program to 20 State Governors, UN Secretary-General Ban Ki-Moon, and the UNFPA Executive Director, Dr Osotimehin on August 23, 2015, and called for continued investment into interventions that save the lives of mothers and newborns.
The Bantwana Initiative ('children' in Zulu) helps children orphaned and made vulnerable by AIDS access the full range of support and comprehensive care they need to grow into healthy adults. To donate please visit www.bantwana.org
The Bantwana Initiative ('children' in Zulu) helps children orphaned and made vulnerable by AIDS access the full range of support and comprehensive care they need to grow into healthy adults.
In a presentation at the Global Health Practitioner Conference, April 13-17, 2015, JSI's Peggy Koniz Booher shared an overview of a literature ant programmatic review on improved nutrition for adolescents, pregnant and lactating women, and women of reproductive age. This presentation included findings from a technical meeting on recommendations on key dietary practices to be used in strengthening policies and programs.
Highlights of the USAID Uganda STAR-EC project. STAR-EC worked to increase access, coverage, and use of quality comprehensive TB and HIV and AIDS services in east and central Uganda. Presentation made at STAR-EC End-of-Project Conference, in Jinja, Uganda, August 2016.
So you think you want a dashboard? Here are a few considerations before you embark on your design process on the questions you should be able to answer. From the MERL Tech "Dashboards: A Force for Good, Great, or Greater Confusion" panel.
Private shops and pharmacies as providers of family planningJSI
Although much work is done to strengthen public health systems, private drug shops/pharmacies are often the first point of care for families in Africa. This powerpoint looks at data snapshots of family planing trends in 15 African countries, such as what family products women buy and who drug shops and pharmacies primarily serve.
2 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...JSI
This presentation by JSI's Nosa Orobaton, "March of Care for Newborn Umbilical Cord in Nigeria" was part of a dynamic panel moderated by JSI's Dr. Penny Dawson on February 13, 2015 at the 14th World Congress on Public Health in Kolkata, India. Four speakers summarized evidence for interventions proven to reduce newborn mortality (e.g., chlorhexidine) and shared important policy and programmatic experiences in prevention and treatment of neonatal infections. JSI's Leela Khanal and Dr. Nosa Orobaton spoke about experiences from Nepal and Nigeria in scaling up chlorhexidine use in those countries. Another speaker shared results from the COMBINE trial in Ethiopia, implemented primarily by JSI with support from SAVE/SNL, which evaluated the impact on neonatal mortality of health extension worker-led management of bacterial infections.
Portfolio Summary: JSI's Work in Research, Monitoring, Evaluation & HISJSI
Learn about JSI's work in M&E, health information systems strengthening, and innovations in data and analytics from the past two years. We highlight examples from our global and US portfolios, including work on Innovations for MNCH, USAID | DELIVER PROJECT, SPRING, our bilateral projects in Ethiopia and Nigeria, and more.
Visualizations with Empathy: Developing Audience PersonasAmanda Makulec
Presentation from Evaluation 2016 featuring ideas for how evaluators (and other data viz designers) can use the develop of personas to segment and understand their audiences. Instead of thinking just of stakeholder groups and job titles, we approach understanding audiences by developing empathy, borrowing from human centered design.
Visualizing Qualitative Information in PowerpointJSI
For JSI's June Designstorm, Tahmid Chowdhury from the Center for Health Information, Monitoring, and Evaluation presented tips and tricks for formatted elegant slidedecks, including tips on using icons, colors, photos, fonts, and more.
Family Planning for All: How an Under-funded Communication Campaign Achieved ...JSI
Presented by Andrea Dickson, Senior Communications Advisor, JSI at the National Conference on Health Communication, Marketing, and Media on August 25, 2016.
1 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...JSI
This presentation by JSI's Leela Khanal, "Better Cord Care Saves Babies' Lives" was part of a dynamic panel moderated by JSI's Dr. Penny Dawson on February 13, 2015 at the 14th World Congress on Public Health in Kolkata, India. Four speakers summarized evidence for interventions proven to reduce newborn mortality (e.g., chlorhexidine) and shared important policy and programmatic experiences in prevention and treatment of neonatal infections. JSI's Leela Khanal and Dr. Nosa Orobaton spoke about experiences from Nepal and Nigeria in scaling up chlorhexidine use in those countries. Another speaker shared results from the COMBINE trial in Ethiopia, implemented primarily by JSI with support from SAVE/SNL, which evaluated the impact on neonatal mortality of health extension worker-led management of bacterial infections.
Data Visualization Design Best Practices WorkshopJSI
This introduction was presented as part of a workshop at the Measurement and Accountability for Results in Health Summit at the World Bank (June 2015). The workshop focused on simple ways anyone working with data can improve their presentations, and included visualization redesign activity to put these principles in practice.
This is the abstract presentation of Dr Harjyot Khosa, which was made as part of the 12th session of 10th Asia Pacific Conference on Reproductive and Sexual Health and Rights (#APCRSHR10) Virtual. This session was held in lead up to #WorldAIDSDay and #16DaysofActivism against sexual and other forms of gender-based violence, on the theme of "HIV/AIDS and sexual and reproductive health and rights (SRHR) in Asia and the Pacific".
Chair: Jennifer Butler, Director, UNFPA Pacific Sub Regional office based in Fiji
Plenary Speaker: Eamonn Murphy, Regional Director, UNAIDS, Asia and the Pacific | “Solidarity and Accountability: HIV, SRHR and the COVID response”
Abstract Presenters:
-------------------------
* Jude Tayaben | Successes, Pitfalls, and Moving Forward: Adivayan Youth Health Center- A school-based program addressing Adolescent Sexuality, and Reproductive Health Issues in Benguet, Philippines
* Samreen, Manisha Dhakal | Integrating transgender health into HIV and SRHR programming in Indonesia, Nepal, Thailand and Vietnam
* Harjyot Khosa | Stigma, sex work and non-disclosure to health care providers: Exploring dynamics of anal sex through community led monitoring to bridge gaps in HIV care continuum services
* Angela Kelly Hanku, Agnes K. Mek | I can, I want, I will and Young & Positive: Two visual method projects with young women living with HIV in Papua New Guinea
For more information on the session, please visit
www.bit.ly/apcrshr10virtual12
Official conference website: www.apcrshr10cambodia.org
Thanks
Sustaining quality approaches for locally embedded community health services ...REACHOUTCONSORTIUMSLIDES
This presentation was given at the Bridging the Quality Gap - Strengthening Quality Improvement in Community Health Services Symposium which was held in September 2016
Quality improvement and Community Health Worker performance: A mixed method r...REACHOUTCONSORTIUMSLIDES
A presentation that describes the REACHOUT approach to studying close-to-community providers with quality improvement interventions designed to improve the performance of programmes.
Cheryl Davenport, Director of Health and Care Integration at Leicestershire County Council, talks about how simulation is helping to evaluate how emergency hospital admissions can be reduced.
Two Examples of Program Planning, Monitoring and EvaluationMEASURE Evaluation
Presented by Laili Irani, Senior Policy Analyst for the Population Reference Bureau, as part of the Measuring Success Toolkit webinar in September 2012.
The Nuffield Trust's Holly Holder presents on a project in partnership with the London School of Economics to evaluate a whole systems approach to integrated care in North West London.
Walter Wodchis: the PRISMA model - approaches to supporting older people to m...The King's Fund
Walter Wodchis, Associate Professor at the Department of Health Policy, Management and Evaluation, University of Toronto, explains how the PRISMA model works.
Started in Quebec in 1999, PRISMA aims to implement an integrated service delivery network to improve the health, empowerment, and satisfaction of frail older people in the community. It also aims to modify their use of health and social services while reducing the burden for their caregivers.
In the PRISMA model, patients enter the system through a single point of entry that assesses, co-ordinates, monitors and evaluates multidisciplinary services being delivered by practitioners, public service providers and volunteer organisations.
In October 2022, the COVID-19 Vaccine Collaborative Supply Planning Initiative (VCSP) held its second in-person retreat for its network of stakeholders and partners involved in COVID-19 vaccine supply planning from global, regional, and country levels. During the retreat, each country presented its COVID-19 vaccine supply planning context at a poster reception. Wish you’d been there? Check out the posters here
Expert Panelists: Dr. Jason Reed, Biomedical HIV Prevention
Technical Advisor, Jhpiego & Dr. More Mungati, STAR-L Director, EGPAF, Lesotho
Moderator: Dr. Seema Ntjabane, Care & Treament Specialist, USAID-Lesotho
Expert panelists:
Dr. Tafadzwa Chakare, Technical Director, Jhpiego, Lesotho
Dr. More Mungati, STAR-L Director, EGPAF Lesotho
Facilitator:
Dr. Seema Ntjabane, Care & Treatment Specialist, USAID-Lesotho
Panelists:
Dr. Abiye Kalaiwo is a Public Health Specialist and USAID's Nigeria's technical lead for Key Populations, managing PEPFAR's
single largest Key Populations program. He has over 12 years of experience in HIV and infectious disease programs at the national level.
Dr. Jason Reed offers more than 12 years of experience in public health surveillance and medical epidemiology, specifically in HIV surveillance systems, prevention programming, and implementation research at state, national and international levels.
At the end of the training, participants will be able to:
State the indications for PrEP
State the eligibility for PrEP
Name the 5 main eligibility criteria for PrEP
Explain how to exclude Acute HIV Infection
Expert Panelists:
Dr. Abiye Kalaiwo, Program Manager, USAID/Nigeria
Dr. Jason Reed, Biomedical HIV Prevention Technical Advisor, Jhpiego
Moderator:
Olawale Durosinmi-Etti, JSI Nigeria
Speakers discuss PrEP counseling, special situations, and other topics covered in training modules three and four. During this webinar, expert speakers review key highlights from modules three and four, and respond to questions from participants.
Part one: https://www.slideshare.net/jsi/prep-elearning-discussion-i
Speakers discuss PrEP eligibility, management, and other topics covered in training modules one and two. During this webinar, expert speakers will review key highlights from the first two modules, share Nigeria specific guidance, and respond to questions from participants.
Part 2: https://www.slideshare.net/jsi/prep-elearning-discussion-2
Presentation by Jeff Sanderson at "Post-Ebola Survivors - Research and Recovery Lessons from West Africa," a USAID Brown Bag on May 2, 2019 at USAID/Crystal City.
Together with NIH/PREVAIL, today’s session focuses on learnings from these programs in relation to survivor care and post-outbreak recovery of health services and health systems.
Facilitator: Jeff Sanderson, Team Leader, West Africa Post-Ebola Programs, JSI R&T/APC
The Presenters:
Dr. Libby Higgs, Global Health Science Advisor for the Division of Clinical Research at NIAID, NIH (confirmed)
Dr. Meba Kagone, former Chief of Party for ETP&SS, Guinea, JSI/APC (confirmed)
Dr. Rose Macauley, former Chief of Party for ETP&SS, Liberia, JSI/APC (confirmed)
Jeff Sanderson (for Dr. Kwame Oneill, former Director of the Program Implementation Unit, Ministry of Health and Sanitation, Sierra Leone)
Background:
The Ebola Transmission Prevention & Survivor Services (ETP&SS) program included four components; country programs in Guinea, Liberia and Sierra Leone, and a regional program designed to share best practices and lessons learned.
ETP&SS assisted these governments to prevent further Ebola transmission, reduce stigma and other barriers to care for survivors when accessing health services, support the strengthening of needed specialty services, and build more resilient and self-sustaining health systems.
The regional program sought to ensure the sharing of lessons learned and best practices across the three countries and the region through meetings, exchanges and conferences with partners such as NIH, WHO, and the West African Consortium.
Funded by the Global Health Bureau through the Advancing Partners & Communities Project, John Snow Research & Training Institute implemented the program from July 2016 through July/August 2018.
Implementing ETP and SS: The Liberia ExperienceJSI
Presentation by Dr. Rose Macauley at "Post-Ebola Survivors - Research and Recovery Lessons from West Africa," a USAID Brown Bag on May 2, 2019 at USAID/Crystal City.
Together with NIH/PREVAIL, today’s session focuses on learnings from these programs in relation to survivor care and post-outbreak recovery of health services and health systems.
Facilitator: Jeff Sanderson, Team Leader, West Africa Post-Ebola Programs, JSI R&T/APC
The Presenters:
Dr. Libby Higgs, Global Health Science Advisor for the Division of Clinical Research at NIAID, NIH (confirmed)
Dr. Meba Kagone, former Chief of Party for ETP&SS, Guinea, JSI/APC (confirmed)
Dr. Rose Macauley, former Chief of Party for ETP&SS, Liberia, JSI/APC (confirmed)
Jeff Sanderson (for Dr. Kwame Oneill, former Director of the Program Implementation Unit, Ministry of Health and Sanitation, Sierra Leone)
Background:
The Ebola Transmission Prevention & Survivor Services (ETP&SS) program included four components; country programs in Guinea, Liberia and Sierra Leone, and a regional program designed to share best practices and lessons learned.
ETP&SS assisted these governments to prevent further Ebola transmission, reduce stigma and other barriers to care for survivors when accessing health services, support the strengthening of needed specialty services, and build more resilient and self-sustaining health systems.
The regional program sought to ensure the sharing of lessons learned and best practices across the three countries and the region through meetings, exchanges and conferences with partners such as NIH, WHO, and the West African Consortium.
Funded by the Global Health Bureau through the Advancing Partners & Communities Project, John Snow Research & Training Institute implemented the program from July 2016 through July/August 2018.
Ebola Transmission Prevention and Survivor Services Program, GuineaJSI
Presentation by Dr. Meba Kagone at "Post-Ebola Survivors - Research and Recovery Lessons from West Africa," a USAID Brown Bag on May 2, 2019 at USAID/Crystal City.
Together with NIH/PREVAIL, today’s session focuses on learnings from these programs in relation to survivor care and post-outbreak recovery of health services and health systems.
Facilitator: Jeff Sanderson, Team Leader, West Africa Post-Ebola Programs, JSI R&T/APC
The Presenters:
Dr. Libby Higgs, Global Health Science Advisor for the Division of Clinical Research at NIAID, NIH (confirmed)
Dr. Meba Kagone, former Chief of Party for ETP&SS, Guinea, JSI/APC (confirmed)
Dr. Rose Macauley, former Chief of Party for ETP&SS, Liberia, JSI/APC (confirmed)
Jeff Sanderson (for Dr. Kwame Oneill, former Director of the Program Implementation Unit, Ministry of Health and Sanitation, Sierra Leone)
Background:
The Ebola Transmission Prevention & Survivor Services (ETP&SS) program included four components; country programs in Guinea, Liberia and Sierra Leone, and a regional program designed to share best practices and lessons learned.
ETP&SS assisted these governments to prevent further Ebola transmission, reduce stigma and other barriers to care for survivors when accessing health services, support the strengthening of needed specialty services, and build more resilient and self-sustaining health systems.
The regional program sought to ensure the sharing of lessons learned and best practices across the three countries and the region through meetings, exchanges and conferences with partners such as NIH, WHO, and the West African Consortium.
Funded by the Global Health Bureau through the Advancing Partners & Communities Project, John Snow Research & Training Institute implemented the program from July 2016 through July/August 2018.
These slides were presented by Dr. Henry Nagai during JSI’s Index Testing & Partner Notification for HIV Epidemic Control webinar on April 11th, 2019. Dr. Nagai is currently the Project Director/Chief of Party for the JSI-implemented USAID Strengthening the Care Continuum project in Ghana with a focus on HIV and key populations. Using funding from USAID and PEPFAR, the Project is improving the capacity of the Government of Ghana and civil society partners to provide quality and comprehensive HIV services for key populations and people living with HIV.
HIV Index Testing: The USAID DISCOVER-Health Project Experience in Zambia JSI
This was presented by Kalasa Mwansa during the Index Testing & Partner Notification for HIV Epidemic Control webinar on April 11th, 2019. The USAID DISCOVER- Health Project Experience aims to increase the use of high quality, integrated health services in specific target groups, and to provide integrated health products and services in a sustainable manner. In addition, it aims to contribute to HIV epidemic control and provides HIV index testing at every ART site.
Root Cause Analysis: A Community Engagement Process for Identifying Social De...JSI
This presentation serves as a training of trainers for the root cause analysis process, where participants will be able to train their organizational staff and community members on the process. In addition, it shows how it can be used for community engagement, coalition building, and to identify the root causes of HIV.
Setting Them up for Failure: Why Parents Struggle to Adhere to Infant Safe Sl...JSI
This poster was presented by Christin D'Ovidio at the National Conference on Health Communication, Marketing & Media.
Each year in Vermont, 4-6 infants die of unsafe sleep environments. The Vermont Department of Health contracted with JSI Research and Training Institute, Inc. (JSI), to study the major barriers Vermont parents and professionals face with regard to infant safe sleep. The research examined: what parents know, have heard, or find confusing about infant safe sleep practices; decisions around infant safe sleep practice; and response to existing infant safe sleep materials.
Some of the major themes with implications for future
communication efforts included parents’ need to be respected as good and competent caregivers, the desire for information that addresses the unique sleep challenges in their family, and
a skepticism of infant safe sleep research and messaging.
Although parents are highly motivated to do what is best for their baby and are aware of the basic infant safe sleep guidelines, parents who struggle the follow the guidelines feel they must choose between sleep and safety, or adapt the guidelines as their version of “safe sleep.”These parents feel they are being set up for failure, due to a lack of guidance to get their baby to sleep in a safe sleep environment. Parents want assistance grounded in the reality of the challenges
and choices they face to get their babies to sleep while keeping
them safe.
Binge-Free 603: What's Your Reason? Preventing Binge Drinking in Young Adults...JSI
This poster was presented by Christin D'Ovidio at the National Conference on Health Communication, Marketing & Media.
Through a contract with the NH Department of Health and Human Services, JSI conducted peer-crowd/peer-group validation and formative research to inform a public health prevention campaign targeting young adults (YA), aged 21-25, identified as most likely to engage in the misuse of alcohol.
The campaign (Binge-Free 603: What’s Your Reason?) addresses binge drinking behaviors and utilizes harm reduction messaging to create an effective marketing mix. JSI used a social norming, a social marketing approach, as the strategic planning framework for developing a campaign to decrease the prevalence of binge drinking in NH YA.
The resulting, highly-targeted campaign includes video production, illustration, social media assets (Facebook, Instagram, Youtube, Snapchat), A/B testing and geo-targeting to further hone effective messaging and reach, and a website.
USAID Community Capacity for Health Program (Mahefa Miaraka)JSI
How Can Population, Health, and Environment Projects Learn from Family Planning High Impact Practices?
JSI’s Yvette Ribaira shares best practices from Madagascar in a new webinar.
On February 6th, JSI population, health, and environment (PHE) expert Dr. Yvette Ribaira shared insights from her experience in Madagascar during a webinar examining the link between PHE programs and high-impact practices (HIPs) drawn from family planning activities.
Watch the webinar here: https://bit.ly/2SKbuvG
Dr. Ribaira, a medical doctor, has spent her career in public health strengthening the Madagascar’s health system, with a specific focus on community health in the last decade. She currently leads the JSI’s USAID Community Capacity for Health Program in Madagascar, locally known as Mahefa Miaraka, which implements the Population Health and Environment (PHE) Activity, funded by Advancing Partners and Communities.
The webinar was hosted by the PACE (https://thepaceproject.org/) (Policy, Advocacy, and Communication Enhanced for Population and Reproductive Health) project and included presenters from the Population Reference Bureau and USAID.
Read more about JSI’s work on population, health, and environment, as well as family planning, in Madagascar and around the world at www.jsi.com
USAID Community Capacity for Health Program (Mahefa Miaraka): Re-engaging Pop...JSI
This presentation was given by Yvette Ribaira at the International Conference on Family Planning (ICFP) in Kigali, Rwanda in November 2018. (This is the English version of the presentation).
In Madagascar, there are 80% endemic species, 80% of the country is rural, 72% of the population is poor, with only 2.7% population growth. There are over exploitation and destruction of natural resources and lack of access to family planning in rural areas.
Program implications:
1. Partnership for integration health, population, environment
2. Coverage in universal health by delegation of tasks to CAs
3. Increased productivity by women and men
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Transitioning from reach every district to reach every community
1. Transitioning from
Reach Every District (RED) to
Reach Every Community (REC)
Dr. Zenaw Adam
Universal Immunization through Improving
Family Health Services (UI-FHS) – Ethiopia/
JSI Research &Training Institute Inc.
EPI Manager’s Meeting for East and Southern Africa
March 9-13 2015,Victoria Falls- Zimbabwe
Ethiopia
2. WHY from District (RED) to Community
(REC)?
• Almost all districts have been reached
with RI
• There are still unreached pockets of
areas and children who are un/under-
vaccinated
• The need for new & flexible
approaches focusing on equitable
services in underserved areas
Reaching
target
populations
Linking
services with
communities
Supportive
supervision
Monitoring
for action
Planning and
management
of resources
3. Concepts in moving from RED to REC
• Customize the approach to suit the context
• Address the “HOW” (facility level analysis,prioritization..etc.)
• Build capacity & partnership between health teams,local
governments and communities
• Build capacity of local health teams to analyze & use own data to
improve situation
4. How to operationalize these concepts?
Main examples to be discussed
Ethiopia:
Using Quality Improvement
(QI) methodology to mobilize
volunteers to identify all
children needing vaccination
Uganda:
Mapping target populations and
health facility catchment areas
for effective immunization
microplanning
5. Ethiopia: RED to REC supported by health
system structure
• Community level structure
– administration with defined area & population
• Community part of local administration
– Membership in kebele cabinet, command post,steering committee
• Health service structure to community level
– Primary Health Care Unit (PHCU) – HCs and HPs
• New Community structures: HDAs & 1-5 network
6. RED-QI: revitalize & operationalize RED by
adding quality improvement (QI) tools
• RED focuses on “WHAT” – to improve performance
• QI focuses on “HOW” - the process of problem analysis,
prioritization and seek local solutions
– Break large problems to smaller,more “do-able” pieces
– Identify small scale changes, promising practices and data to share
with peers on a regular basis
– Process improvements: find positive deviance examples, local
solutions,contextualize and test others’ successes
7. Putting the pieces together:
RED-QI to REC-QI
REC-QI
SupportiveSupervision
• QITs at management and service levels;
community membership
• Bottom-up microplanning : key in district
and facility planning
• Data analysis using RED categorization
tool,and its use at district,HC and HP
levels
• Supportive supervision (PBSS/ISS)
• Quarterly and monthly review meetings
(QRMs)
8. RED-QI: using Plan-Do-Study-Act (PDSA)
cycles
What are we trying to
accomplish?
How will we know that a
change is an improvement?
What change can we make that
will result in improvement?
Model for Improvement
PlanAct
DoStudy
• Identify problems and detailed analysis
(fishbone analysis)
• Prioritize the problems
• Select a problem and list change ideas for
solutions
• Implement one change idea for a short
period & study results
• Then Adopt,Adapt (orAbandon) the
change ideas
9. RED-QI Continued
Quality Improvement Teams (QIT) in Ethiopia
• QITs at management and service levels.
• District Health Office (management only)
• Health Center (management and service)
• Health Post at community level (service only)
• QIT at community level is particularly crucial
• Women with their network(s) are key members
10. RED/C-QI in action: examples
PDSA Experience in Hintalo Wajerate
district
A cluster of facilities (PHCU):1 HC, 6 HPs, ≈10 OR
– 25,000 population
• 4,600 women aged 15-44
• 560 children <1 yr
– Providers:6 HEWs,24 community volunteers
– Support by women’s group (WDA),each leading sub-groups of
‘one-to-five’ networks
11. PDSA Experience in HW district
CHANGE IDEA: visit each HH to register newborns,
unimmunized and defaulter children.
AIM: Increase coverage from 85% to 95% in 3 months
• Plan: QIT meetings:health workers and community
• Do: EnlistedWDAs to go house to house to list <1 children
• Study:
• 25 defaulters found and vaccinated
• 68 newborns and never-immunized found; follow up with 45 of
unimmunized starting vaccination
• Productive community effort improved coverage
• Act: Adopt the change idea and apply for other programs
12. Uganda: Mapping target populations
for facility catchment areas
• Macro mapping: a continuous process to identify and assign
communities (parish level) to facilities to enable effective health
service delivery
• Micro mapping: a continuous process to identify and assign
communities (village level) within a health facility catchment area to
RI service delivery points,both static and outreach
13. Macro-mapping process: How is it done?
1. District assembles key inputs
2. Prepare first draft of facility catchment area macro map
3. Build consensus on macro map
14. Criteria for assigning communities to HF
1. Proximity of community to HF
2. Access to HF – geographic,economic
3. Capacity of HF to serve communities - RI
• Transport
• Health workers
• Adequacy of vaccines & supplies
4. HF already providing services
15. Micro-mapping process
1. Assemble key inputs (includes
macro map and list of static and
outreach RI service delivery points)
2. Prepare first draft of facility micro
map:
3. Harmonize and build consensus on
micro map
16. Results and Applications of Mapping Process
Enhances planning and monitoring:
– Provides accurate basis for RED microplanning
– Enables identification of communities previously unreached with
RI
– Improves efficiency of resource allocations
– Strengthens community links to RI services
– Improves convenience of RI services to caretakers and fosters
better communication
– Provides target populations for other services
18. RED/C-QI in Action: Examples
Zimbabwe: (Manicaland)
• Most populated province with low penta3 coverage of 52%
(2010 DHS)
• MCHIP PHO collaborated to implement RED components
– RED micro planning in all districts
– VHWs mobilize eligible infants and trace defaulters
– Conducted regular supportive supervision
– HFs updated monitoring chart monthly
– HFs defined target population-counting of kids usingVHWs
• Provincial penta 3 coverage >80% in 2013 (c.survey)
19. Operationalizing the REC Approach - Kenya
19
Continuous
monitoring process
includes essential
elements:
• Review meetings
• Peer-learning
• Self-assessment
20. Impact of REC in focus districts - Kenya
-1000
0
1000
2000
3000
4000
5000
6000
Bungoma
south
Vihiga Bungoma
North
Siaya Bondo Rachuonyo Kisumu
East
No.Ofchildren
District
Number of under-vaccinated children (with Penta 3), 2009-2012
2009
2010
2011
2012
21. Conclusions
• Circumstances in Ethiopia and other countries are conducive
and timely for the transition of RED to REC.
• Applying QI to REC provides an effective tool to operationalize
and revitalize the strategy
• REC-QI approach combines ‘WHAT’ & ‘HOW’ to strengthen
the RI system and fosters local solutions and ownership of the
program
22. Conclusions (continued)
• Brings together all EPI stakeholders,including non- traditional ones
– advocacy, resource mobilization
• RED-QI encourages innovation and is applicable to all other family
health services
• Peer learning on REC-QI and incorporation of innovations into
national policies,guidelines and tools is enhanced by working at
national and subnational levels